Abbott Laboratories
US.ABT
108.33
-0.46
-0.42%
Abbott Laboratories
108.33
-0.46
-0.42%
Collector offline (last heartbeat: 19188s ago)
· 2026-09-04 20:02
Pre-market
107.99
-0.73%
After-hours
108.33
0.00%
Overnight
108.50
-0.27%
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 13 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 80.69% -0.02pp
- Institutions
- 3,382 -13
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund65.18%
Public Company4.61%
Hedge Fund3.36%
Private Company3.00%
Government Pension Fund1.83%
Sovereign Wealth Fund1.41%
Family Office/Trust0.58%
Individual/Insider0.49%
Corporate Pension Plan0.22%
Other19.32%
Top holders
| Holder | Stake |
|---|---|
| BlackRock | 8.82% |
| Vanguard Capital Management, LLC | 7.14% |
| State Street Global Advisors | 4.68% |
| Capital Research | 4.21% |
| Charles Schwab Investment Management | 3.45% |
| Other | 71.71% |
Insiders
27 filings tracked · 15 buys · 3 sells
| Name | Role | Stake |
|---|---|---|
| Daniel Starks | Independent Director | 0.39% |
| Robert Ford | Chairperson & CEO | 0.03% |
| Robert Funck | Officer | 0.02% |
| Hubert Allen | General Counsel | 0.01% |
| Daniel Salvadori | Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 0.01% |
| Mary Moreland | Officer | 0.01% |
| Lisa Earnhardt | Executive Vice President of Medical Devices | 0.01% |
| Philip Boudreau | CFO & Senior VP of Finance | 0.00% |
| Christopher Scoggins | Former Senior Vice President of Rapid Diagnostics | 0.00% |
| Andrea Wainer | Executive Vice President of Rapid & Molecular Diagnostics | 0.00% |
Quote time 2026-09-04 20:02:35
For reference only, not investment advice.